June 3, 2021 – Provincial government update on the COVID-19 pandemic
Here is an update on recent decisions and actions by the provincial government in connection with the COVID-19 pandemic.
Vaccination schedule for the second dose
Minister of Health and Social Services Christian Dubé announced the schedule for administering the second dose of the COVID-19 vaccine.
Changes to appointments will begin on June 7 and will proceed by age group on the Clic Santé platform, according to the following schedule:
- June 7: 80 years old and over
- June 8: 75 years old and over
- June 9: 70 years old and over
- June 10: 65 years old and over
- June 11: 60 years old and over
- June 14: 55 years old and over
- June 15: 50 years old and over
- June 16: 45 years old and over
- June 17: 40 years old and over
- June 18: 35 years old and over
- June 21: 30 years old and over
- June 22: 25 years old and over
- June 23: 18 years old and over
First vaccination objective attained
“We’re very pleased to announce that the objective of vaccinating 75% of the adult population was attained three weeks earlier than expected,” said Christian Dubé.
The Québec government has set the objective of administering both doses of the vaccine to 75% of people aged 12 and over by August 31.
Eight weeks between doses
Minister Dubé reduced the minimum recommended interval between the two injections to eight weeks for all the vaccines, based on the recommendations of the Comité sur l’immunisation du Québec (CIQ).
For people who are immunocompromised or on dialysis, the interval will be four weeks.
“For the mRNA vaccines (Pfizer and Moderna), the recommended interval for most people will decrease from 16 to 8 weeks or more in order to attain a greater immune response, more quickly. It is important that the offer to shorten the interval between the two doses roll out according to the schedule based on priority age groups, since older people present greater risks of developing complications from COVID-19,” said Minister Dubé.
For the AstraZeneca vaccine, the eight-week interval has been found to be effective, but the protection could be greater with an interval of 12 weeks or more between doses.